Why Use Dimensionless Regimes?
A TMDD parameter set can contain association and dissociation rates, target turnover, internalization, linear drug clearance, and dose scales. Their raw numerical values do not by themselves show which processes dominate: a rate of \(0.1\) per day can be fast relative to one process and slow relative to another. Dimensionless ratios put these rates and concentrations on comparable scales. They help organize expectations about whether target binding materially changes disposition, whether binding develops slowly relative to changing exposure, and whether the available target-mediated removal capacity is limited relative to the drug amount.
These regimes are guides to interpretation, not mutually exclusive model types with universal numerical boundaries. A system can have rapid binding and a capacity-limited target sink at the same time. It can also move between regimes over a concentration-time profile. The appropriate comparisons are therefore tied to the model, the time window, and the concentration range of interest.
Model and Scaling
Use the canonical one-compartment TMDD mass-balance model. Let \(D\) be free drug concentration, \(R\) free target concentration, and \(C\) drug-target complex concentration. Drug binds target with association rate constant \(k_{\mathrm{on}}\), dissociates with rate constant \(k_{\mathrm{off}}\), and complex is internalized with rate constant \(k_{\mathrm{int}}\). Free target is synthesized at rate \(k_{\mathrm{syn}}\) and degraded at rate \(k_{\mathrm{deg}}\); free drug is eliminated linearly at rate constant \(k_{\mathrm{el}}\). An input \(I(t)\), in concentration per time, may represent systemic drug input. Assume one-to-one binding, a well-mixed shared compartment, nonnegative concentrations, and constant rate parameters. In the absence of drug, baseline target is \(R_0=k_{\mathrm{syn}}/k_{\mathrm{deg}}\).
Scale all three concentrations by \(R_0\), and scale time by the baseline target-turnover rate: \(\tau=k_{\mathrm{deg}}t\), \(d=D/R_0\), \(r=R/R_0\), and \(c=C/R_0\). The resulting dimensionless groups are
Substitution into the mass balances gives
For example, the association term becomes \(k_{\mathrm{on}}DR/(k_{\mathrm{deg}}R_0)=\beta dr\). This scaling makes explicit that binding depends on both the intrinsic association rate and target abundance: the same \(k_{\mathrm{on}}\) can imply different binding behavior at different \(R_0\). The ratios \(\delta/\beta\) and \(\gamma\) also have useful interpretations. Since \(K_D=k_{\mathrm{off}}/k_{\mathrm{on}}\), \(\delta/\beta=K_D/R_0\); and \(\gamma\) compares complex internalization with baseline target turnover.
Rate Scales and Dose Scales
Binding kinetics must be compared with the rates at which free drug and target conditions change. At a specified free drug concentration \(D_*\), a useful local binding-relaxation timescale is approximately \(1/(k_{\mathrm{on}}D_*+k_{\mathrm{off}}+k_{\mathrm{int}})\). This is a scale estimate for complex formation and loss, not an exact relaxation time for the coupled three-equation system. Compare it with relevant exposure and target timescales, including \(1/k_{\mathrm{el}}\) and \(1/k_{\mathrm{deg}}\). If complex formation and loss are fast compared with changing exposure, binding is not likely to be rate-limiting. If association is slow at the concentrations actually reached, or complex formation adjusts slowly relative to drug disappearance, the trajectory can be binding-limited even when the equilibrium affinity is high.
Dose and affinity are separate considerations. The dimensionless concentration \(d_*=D_*/R_0\) compares free drug concentration with baseline target concentration. The affinity comparison \(D_*/K_D\) indicates whether the free drug concentration is low or high relative to the dissociation constant. A large \(D_*/K_D\) favors substantial occupancy when binding has time to occur, but it does not establish that the target sink is large relative to drug exposure. Conversely, \(D_*/R_0\) compares concentration scales, not the total dose with total target amount unless the effective volumes are the same.
A finite target pool also constrains the instantaneous complex concentration: \(C\) cannot exceed total available target in the compartment. In the stated model, internalization removes complex at rate \(k_{\mathrm{int}}C\), so the instantaneous internalization flux is bounded by \(k_{\mathrm{int}}\) times the available target concentration. Target synthesis can replenish target over time, so cumulative removal capacity over a long interval is not simply the initial target amount. A rough nominal capacity scale over duration \(T\) includes both the initial target pool and possible replenishment, whose baseline amount is \(k_{\mathrm{syn}}T=k_{\mathrm{deg}}R_0T\). The actual capacity depends on target dynamics and occupancy.
Classifying the Main Regimes
The following comparisons provide a practical classification. Use concentrations and rates from the range the model is intended to describe, and revisit the classification as drug concentration changes.
| Regime | Useful comparison | Interpretation |
|---|---|---|
| TMDD negligible | Target-mediated drug loss is small relative to linear loss, and complex formation or sequestration is small over the relevant interval. | A linear disposition description may be adequate for that dose range and time window, although the target can still be pharmacologically important. |
| Binding-limited | Association at achieved concentrations, or complex adjustment, is slow relative to exposure change or relevant turnover. | Binding does not respond rapidly enough to exposure for an equilibrium-style intuition to describe the transient trajectory. |
| Capacity-influenced | Drug exposure is comparable to or exceeds target binding capacity, or the target-mediated removal flux is comparable to the linear drug-loss flux. | Target-mediated removal can be important at lower exposure yet become relatively less influential as drug amount rises or target capacity is approached. |
A direct trajectory diagnostic for the importance of irreversible target-mediated drug loss is the ratio \(k_{\mathrm{int}}C/(k_{\mathrm{el}}D)\), where \(D>0\). It compares internalization-mediated drug loss with linear drug loss at that instant. A small ratio throughout the interval supports negligible target-mediated clearance relative to linear clearance. It does not rule out substantial temporary sequestration: if \(C\) is large relative to \(D\), total drug \(D+C\) can differ materially from free drug even when internalization is slow. Examine both fluxes and the amount in complex when deciding whether TMDD is negligible for the question being asked.
Worked Examples
Worked Example: Rapid Binding With a Capacity-Relevant Sink
Suppose a hypothetical system has \(R_0=10\) nM, \(k_{\mathrm{deg}}=0.10\) day\(^{-1}\), \(k_{\mathrm{on}}=0.020\) nM\(^{-1}\) day\(^{-1}\), \(k_{\mathrm{off}}=0.20\) day\(^{-1}\), \(k_{\mathrm{int}}=0.30\) day\(^{-1}\), and \(k_{\mathrm{el}}=0.050\) day\(^{-1}\). Consider an initial free drug concentration \(D_*=100\) nM.
The dimensionless rate groups are \(\beta=(0.020)(10)/0.10=2.00\), \(\delta=0.20/0.10=2.00\), \(\gamma=0.30/0.10=3.00\), and \(\lambda=0.050/0.10=0.500\). The affinity scale is \(K_D=k_{\mathrm{off}}/k_{\mathrm{on}}=0.20/0.020=10.0\) nM. Thus \(D_*/K_D=100/10=10.0\), and \(D_*/R_0=100/10=10.0\).
At this concentration, the association rate scale is \(k_{\mathrm{on}}D_*=(0.020)(100)=2.00\) day\(^{-1}\). The approximate complex adjustment rate is \(2.00+0.20+0.30=2.50\) day\(^{-1}\), compared with \(k_{\mathrm{el}}=0.050\) day\(^{-1}\) and \(k_{\mathrm{deg}}=0.10\) day\(^{-1}\). Binding is fast relative to these reference rates. However, rapid binding does not mean unlimited target-mediated removal. At baseline target concentration the maximum nominal internalization flux is \(k_{\mathrm{int}}R_0=(0.30)(10)=3.00\) nM/day, while initial linear drug loss is \(k_{\mathrm{el}}D_*=(0.050)(100)=5.00\) nM/day. The target-mediated flux is capacity-relevant on this scale, but is not larger than linear loss. The appropriate classification is rapid binding with a finite, potentially material target sink—not binding-limited and not negligible by assumption.
Worked Example: Conditions Supporting Negligible TMDD
For a second hypothetical system, let \(R_0=2.00\) nM, \(k_{\mathrm{deg}}=0.050\) day\(^{-1}\), \(k_{\mathrm{on}}=0.0010\) nM\(^{-1}\) day\(^{-1}\), \(k_{\mathrm{off}}=0.10\) day\(^{-1}\), \(k_{\mathrm{int}}=0.050\) day\(^{-1}\), and \(k_{\mathrm{el}}=0.20\) day\(^{-1}\). Suppose the initial free drug concentration is \(0.200\) nM.
Here \(K_D=0.10/0.0010=100\) nM, so \(D_*/K_D=0.200/100=0.00200\), and \(D_*/R_0=0.200/2.00=0.100\). Association at the starting concentration has rate \(k_{\mathrm{on}}D_*=(0.0010)(0.200)=0.000200\) day\(^{-1}\), far below the linear elimination rate \(0.20\) day\(^{-1}\). The initial linear loss rate is \(k_{\mathrm{el}}D_*=(0.20)(0.200)=0.0400\) nM/day. Even the baseline-target nominal internalization bound is only \(k_{\mathrm{int}}R_0=(0.050)(2.00)=0.100\) nM/day; this loose upper bound alone does not prove negligible TMDD, because actual occupancy may be very small.
For an initial free-target state \(R=R_0\), \(C=0\), the initial complex formation rate is \(k_{\mathrm{on}}D_*R_0=(0.0010)(0.200)(2.00)=0.000400\) nM/day. Its small size relative to the \(0.0400\) nM/day linear loss, together with \(D_*/K_D=0.00200\), supports little initial target binding in this exposure range. The conclusion is conditional: if concentrations or exposure duration were much larger, the ratios and the integrated amount bound would need to be reassessed.
Worked Example: High Affinity but Binding-Limited Transients
Consider a third hypothetical system with \(R_0=5.00\) nM, \(k_{\mathrm{deg}}=0.050\) day\(^{-1}\), \(k_{\mathrm{on}}=0.0010\) nM\(^{-1}\) day\(^{-1}\), \(k_{\mathrm{off}}=0.00010\) day\(^{-1}\), \(k_{\mathrm{int}}=0.00020\) day\(^{-1}\), and \(k_{\mathrm{el}}=0.20\) day\(^{-1}\). Let \(D_*=20.0\) nM.
The dissociation constant is \(K_D=0.00010/0.0010=0.100\) nM, giving \(D_*/K_D=200\). Equilibrium affinity strongly favors binding at this concentration. Yet the association rate scale is only \(k_{\mathrm{on}}D_*=(0.0010)(20.0)=0.0200\) day\(^{-1}\); the approximate complex adjustment rate is \(0.0200+0.00010+0.00020=0.0203\) day\(^{-1}\). This is about one tenth of the linear elimination rate, \(0.20\) day\(^{-1}\). Over one day, the initial complex formation rate at \(R=R_0\) is \((0.0010)(20.0)(5.00)=0.100\) nM/day, whereas initial linear loss is \((0.20)(20.0)=4.00\) nM/day.
Thus, high affinity does not imply rapid capture during a changing exposure. With the stated starting conditions, binding is slow relative to drug elimination and is plausibly binding-limited during the early transient. This comparison does not establish the later trajectory: if drug persists, binding can accumulate over time, and the full mass-balance model is needed to quantify it.
Derivation and Practical Interpretation
The central scaling result follows directly from changing units in the mass balances. With \(D=R_0d\), \(R=R_0r\), \(C=R_0c\), and \(\tau=k_{\mathrm{deg}}t\), the chain rule gives \(dD/dt=R_0k_{\mathrm{deg}}\,dd/d\tau\). Dividing the drug equation by \(R_0k_{\mathrm{deg}}\) yields \(-k_{\mathrm{el}}D/(R_0k_{\mathrm{deg}})=-\lambda d\), \(-k_{\mathrm{on}}DR/(R_0k_{\mathrm{deg}})=-\beta dr\), and \(+k_{\mathrm{off}}C/(R_0k_{\mathrm{deg}})=+\delta c\). Applying the same substitutions to the target and complex equations gives the dimensionless system above. Consequently, changes in a dimensional parameter matter through their effects on groups such as \(\beta,\delta,\gamma,\lambda\), along with the initial or input concentration scale \(d\).
A capacity comparison is necessarily more contextual than the rate scaling. At a given moment, \(k_{\mathrm{int}}C\) is the target-mediated irreversible drug loss rate, and \(k_{\mathrm{el}}D\) is the linear loss rate. Their ratio is a direct comparison of modeled fluxes. By contrast, the ratio \(D_*/R_0\) is an initial concentration-scale comparison: it suggests whether the drug concentration scale is small or large relative to baseline target, but does not by itself account for tissue distribution, target replenishment, or how much drug is delivered over time. State which comparison is being used and what it can establish.
Useful diagnostics follow from the same distinctions. If a model predicts appreciable complex formation despite an association timescale much longer than drug exposure, check units, initial conditions, and the computed trajectory. If the analysis calls TMDD negligible solely because the internalization flux is small, inspect complex abundance as well: substantial reversible binding can alter free-drug exposure without a large internalization flux. If a capacity argument uses a total administered dose, verify that dose and target amount refer to compatible volumes and that replenishment over the interval has not been ignored.
Choosing and Interpreting a Regime
A linear disposition model is a reasonable alternative only when target binding and target-mediated loss are small for the intended exposure range and outcome. A capacity-influenced regime instead calls for attention to target-mediated flux and finite target availability across concentrations. A binding-limited regime requires retaining the time dependence of binding rather than assuming that affinity alone determines transient occupancy. These descriptions do not substitute for fitting or simulating the specified TMDD equations; they indicate which scales merit attention and what simplification would need justification.
Regime labels have limitations. They depend on the assumed compartment and parameterization, and a single dose can traverse multiple regimes as \(D\) falls. Baseline \(R_0\) is a useful scale, not a guarantee that target remains at baseline during drug exposure. Uncertainty in target abundance or kinetic rates can also change the relevant ratios. For advanced analysis, calculate dimensionless groups over plausible parameter ranges and evaluate fluxes along the predicted trajectory rather than relying on a single nominal number.
Common Pitfalls
- Equating high affinity with fast binding. A small \(K_D\) can result from a very small \(k_{\mathrm{off}}\), even when \(k_{\mathrm{on}}\) is slow. Compare kinetic rates with exposure timescales.
- Calling a target sink negligible from dose-to-target ratio alone. \(D_*/R_0\) is a concentration comparison, not a direct measurement of internalization flux. Also examine \(k_{\mathrm{int}}C\) relative to \(k_{\mathrm{el}}D\).
- Assuming capacity is fixed at the initial target amount. Target synthesis can replenish the pool during treatment; capacity depends on duration and target dynamics.
- Treating regime labels as exclusive. Fast binding can coexist with capacity limitation, and the dominant regime can change as concentration declines.
Check Your Understanding
Answer each question using the model assumptions and comparisons described above. Brief solutions follow the questions.
- If \(k_{\mathrm{on}}D_*\) is small relative to \(k_{\mathrm{el}}\), what does that suggest, and what additional comparison is needed before calling TMDD negligible?
- A drug has \(D_*/K_D=50\) but \(k_{\mathrm{on}}D_*\) is much slower than drug elimination. Which distinction does this illustrate?
- For \(k_{\mathrm{int}}=0.10\) day\(^{-1}\), \(C=3.0\) nM, \(k_{\mathrm{el}}=0.20\) day\(^{-1}\), and \(D=6.0\) nM, calculate the ratio of internalization-mediated to linear drug loss.
- Why is \(D_*/R_0\) not automatically the ratio of total drug amount to total target amount?
Solutions. (1) It suggests slow association at that concentration relative to drug disappearance, so binding may be kinetically limited. To assess negligible TMDD, also compare actual target-mediated loss \(k_{\mathrm{int}}C\) with linear loss \(k_{\mathrm{el}}D\), and consider complex sequestration over the interval. (2) High affinity and rapid binding are distinct: the ratio \(D_*/K_D\) concerns affinity relative to concentration, whereas \(k_{\mathrm{on}}D_*\) is a kinetic rate. (3) The ratio is \((k_{\mathrm{int}}C)/(k_{\mathrm{el}}D)=[(0.10)(3.0)]/[(0.20)(6.0)]=0.30/1.20=0.250\). At that instant, internalization-mediated loss is one quarter of linear loss. (4) The values are concentrations. Converting them to amounts requires compatible distribution volumes; drug and target may not occupy the same effective volume.